Gate2Brain — Grant · approximately €700K

Gate2Brain was awarded over €700K from CDTI Innovación's Multipaís 2024 programme, under the PERTE Salud de Vanguardia and funded by NextGenerationEU. The money supports a collaboration with India to finish G2B-002's regulatory preclinical work and reach a paediatric clinical trial by the end of 2027.